Results: 12
Targeting Interferon Signalling in Systemic Lupus Erythematosus: Lessons Learned.
- Published in:
- Drugs, 2024, v. 84, n. 6, p. 625, doi. 10.1007/s40265-024-02043-2
- By:
- Publication type:
- Article
Correction: Ruxolitinib Cream 1.5%: A Review in Non-Segmental Vitiligo.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Therapeutic Potential of Lipoprotein(a) Inhibitors.
- Published in:
- Drugs, 2024, v. 84, n. 6, p. 637, doi. 10.1007/s40265-024-02046-z
- By:
- Publication type:
- Article
Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan.
- Published in:
- Drugs, 2024, v. 84, n. 6, p. 661, doi. 10.1007/s40265-024-02037-0
- By:
- Publication type:
- Article
Understanding Differences in Sex-Based Outcomes with Dual Antiplatelet Therapy After Percutaneous Coronary Intervention.
- Published in:
- Drugs, 2024, v. 84, n. 6, p. 703, doi. 10.1007/s40265-024-02041-4
- By:
- Publication type:
- Article
Ensitrelvir Fumaric Acid: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 6, p. 721, doi. 10.1007/s40265-024-02039-y
- By:
- Publication type:
- Article
Postpartum Depression: A Clinical Review of Impact and Current Treatment Solutions.
- Published in:
- Drugs, 2024, v. 84, n. 6, p. 645, doi. 10.1007/s40265-024-02038-z
- By:
- Publication type:
- Article
Resmetirom: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 6, p. 729, doi. 10.1007/s40265-024-02045-0
- By:
- Publication type:
- Article
Cefepime/Enmetazobactam: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 6, p. 737, doi. 10.1007/s40265-024-02035-2
- By:
- Publication type:
- Article
Sex-Based Outcomes of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis.
- Published in:
- Drugs, 2024, v. 84, n. 6, p. 685, doi. 10.1007/s40265-024-02034-3
- By:
- Publication type:
- Article
Tegileridine: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 6, p. 717, doi. 10.1007/s40265-024-02033-4
- By:
- Publication type:
- Article
Crovalimab: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 6, p. 707, doi. 10.1007/s40265-024-02032-5
- By:
- Publication type:
- Article